• FLEXcyte 96

    在柔性膜上培养的心肌细胞
  • FLEXcyte 96

    测量真实的心肌收缩力
  • FLEXcyte 96

    整套设备可放置在台面上
  • FLEXcyte 96

    一目了然地判断药物反应

2020 - Mechanobiology of in vitro assays: Tackling prevailing challanges in pre-clinical drug development

Icon FLEX    FLEXcyte 96 presentation (slide deck)  logo pdf (1.5 MB)

Presenter:
Dr. Matthias Gossmann
co-founder and CEO at InnoVitro, Germany

Source:
The 64th Annual Meeting of the Biophysical Society, San Diego, CA (USA)
Feb 15-19. 2020

Abstract:
Common systems for the quantification of cellular contraction rely on animal-based models, complex experimental setups or indirect approaches. Integration into standard lab procedures remains a challenge for current in vitro systems. The FLEXcyte 96 system has the potential to scale-up mechanical testing towards medium-throughput analyses. We show here that, using stem cell-derived cardiomyocytes, this system enables predictive recordings of contractile behaviour in the presence of well-known reference compounds.

返回总览

 

FLEXcyte 96 Brochure

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.